SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001811764-23-000046
Filing Date
2023-11-13
Accepted
2023-11-13 07:15:36
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pnt-20230930.htm   iXBRL 10-Q 1192583
2 EX-31.1 exhibit311-10qx09302023.htm EX-31.1 11342
3 EX-31.2 exhibit312-10qx09302023.htm EX-31.2 12085
4 EX-32 exhibit32-10qx09302023.htm EX-32 8848
  Complete submission text file 0001811764-23-000046.txt   6762234

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pnt-20230930.xsd EX-101.SCH 45368
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pnt-20230930_cal.xml EX-101.CAL 75880
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pnt-20230930_def.xml EX-101.DEF 198823
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pnt-20230930_lab.xml EX-101.LAB 662424
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pnt-20230930_pre.xml EX-101.PRE 418748
74 EXTRACTED XBRL INSTANCE DOCUMENT pnt-20230930_htm.xml XML 927337
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39373 | Film No.: 231395070
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences